Dorothee Kern

Dorothee Kern
Born19 January 1966 (1966-01-19) (age 58)[1]
Halle, Germany
SpouseGunther Kern
Children
Awards
Academic background
Education
ThesisNMR-spektroskopische Untersuchungen zur Dynamik der Cis-trans-Isomerisierung am Prolin und deren Katalyse durch Cyclophilin (1995)
Academic work
DisciplineBiochemistry
InstitutionsBrandeis University

Dorothee Kern, (born 1966) is a professor of Biochemistry at Brandeis University[2] and former player for the East German national basketball team.[3]

In 2016, she cofounded Relay Therapeutics,[4] a Massachusetts-based drug research company studying the motion of proteins using genomic data and computational biology.[5] In 2020, she cofounded MOMA Therapeutics, a company working on drug discovery.[6]

In 2017 she became a member of the German Academy of Sciences Leopoldina,[7] a scientific advisory body to the German government and citizens that serves as a liaison between the German scientific community and the rest of the world.[8]

  1. ^ "Kern CV" (PDF). Archived (PDF) from the original on 2019-10-09.
  2. ^ "Life Sciences Faculty - Dorothee Kern". www.bio.brandeis.edu. Retrieved 2018-03-25.
  3. ^ Curry, Andrew: "Big Dreams Come True", Science, 326:792
  4. ^ Tong, Amber (July 16, 2020). "Relay reaps $400M IPO windfall after drawing the curtain on motion-based drug design pipeline". Endpoints News. Archived from the original on 2020-07-18. Retrieved 2021-09-17.
  5. ^ "Our Team". Relay Therapeutics. Retrieved 2021-09-14.
  6. ^ "Dorothee Kern's path from basketball star to founder of billion-dollar biotech(s?); Five Prime Therapeutics hands the reins to Genentech vet". Endpoints News. April 17, 2020. Archived from the original on 2020-04-20. Retrieved 2021-09-17.
  7. ^ "Dorothee Kern". German Academy of Sciences Leopoldina. Retrieved 26 May 2021.
  8. ^ "Leopoldina Mission Statement". Nationale Akademie der Wissenschaften Leopoldina. Retrieved 2021-11-21.